
|Articles|July 31, 2016
Diabetes, HCV Drug Approvals Highlight AJPB Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
2
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
3
Updates in Treatment of Unresectable Hepatocellular Carcinoma
4
Notable Updates in Medication Therapy Management in 2025
5









































































































































































































